Pivot Bio Stock

pivotbio.comFoodTech / AgTechFounded: 2010Funding to Date: $1.41B

Pivot Bio develops solutions to grow environmentally-responsible and sustainably focused food crops. The company leverages biology, machine learning and computational modeling to reawaken microbes’ natural ability to convert nitrogen from the air to meet crops’ daily nitrogen needs, thus reducing the use of traditional fertilizers.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for Pivot Bio, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

Pivot Bio Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Pivot Bio Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
07/23/2024 Series E $150MM $xx.xx $1.57B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
26,302,263
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
07/19/2021 Series D $434.54MM $xx.xx $1.7B Temasek Holdings, Tekfen Ventures, Roger Underwood, Rockefeller Capital Management, Prelude Ventures, Pavilion Capital, Generation Investment Management, G2VP, DCVC
Price per Share
$xx.xx
Shares Outstanding
57,270,060
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Temasek Holdings, Tekfen Ventures, Roger Underwood, Rockefeller Capital Management, Prelude Ventures, Pavilion Capital, Generation Investment Management, G2VP, DCVC
04/30/2020 Series C $105MM $xx.xx $495.12MM Breakthrough Energy Ventures, Temasek, DCVC, Prelude Ventures, Spruce Capital Partners, Codon Capital, Bunge Ventures, Continental Grain Company, Tefken Ventures, Pavilion Capital, Alan Cohen, Roger Underwood
Price per Share
$xx.xx
Shares Outstanding
36,107,200
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Breakthrough Energy Ventures, Temasek, DCVC, Prelude Ventures, Spruce Capital Partners, Codon Capital, Bunge Ventures, Continental Grain Company, Tefken Ventures, Pavilion Capital, Alan Cohen, Roger Underwood
10/02/2018 Series B $71.33MM $xx.xx $210.81MM Breakthrough Energy Ventures, Temasek, Teken Ventures
Price per Share
$xx.xx
Shares Outstanding
37,248,430
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Breakthrough Energy Ventures, Temasek, Teken Ventures
01/13/2016 Series A $16MM $xx.xx $30.77MM OS Fund, Monsanto Growth Ventures, Genoa Ventures, DCVC, Bill & Melinda Gates Foundation
Price per Share
$xx.xx
Shares Outstanding
24,955,520
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OS Fund, Monsanto Growth Ventures, Genoa Ventures, DCVC, Bill & Melinda Gates Foundation
10/01/2014 Series Seed $999,996 $xx.xx $1.67MM Monsanto Growth Ventures, DCVC
Price per Share
$xx.xx
Shares Outstanding
3,846,140
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Monsanto Growth Ventures, DCVC

Pivot Bio investors also invested in these private companies

Leadership & Board

Leadership

Karsten Temme
Chief Executive Officer
Alvin Tamsir
Chief Scientific Officer
Lisa Nunez Safarian
Chief Operating Officer
Doug Jeffries
Chief Financial Officer
John Walls
Chief Information Officer
Devang Shah
General Counsel
Evan Wittenberg
Chief People Officer

Board

Chris Abbott
Continental Grain Company
Susan Kim
PacBio
Monica McGurk
Tropicana and Mainstream Brands
Matt Ocko
DCVC (Data Collective)
Ryan Rakestraw
Temasek
Cooper Rinzler, Ph.D.
Breakthrough Energy

Pivot Bio stock FAQs

plusminus

Can you buy Pivot Bio stock?

As Pivot Bio is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Pivot Bio, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy Pivot Bio stock?

To invest in a private company like Pivot Bio through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Pivot Bio stock?

Yes, you may sell the Pivot Bio stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Pivot Bio stock?

If you hold private company shares of Pivot Bio – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Pivot Bio on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Pivot Bio a public company?

No, Pivot Bio is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Pivot Bio’s stock price?

Pivot Bio is a privately held company and therefore does not have a public stock price. However, you may access Pivot Bio private market stock price with Forge Data.
plusminus

What is Pivot Bio’s stock ticker symbol?

Pivot Bio does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Pivot Bio’s news and media highlights

Pivot Bio, Inc., known for delivering sustainability-focused crop nutrition, has named Chris Abbott its Chief Executive Officer effective immediately, according to a press release from the company. Already announced, Pivot Bio co-founder and current CEO Karsten Temme is stepping into the Chief Innovation Officer role.
Nitrogen innovator Pivot Bio‘s revenue hit a milestone by surpassing the $100 million mark, the company reports in its FY2023 results.
Pivot Bio, a sustainable agriculture company, has released data showing its products helped farmers avoid approximately 226,400 metric tons of carbon emissions in 2022, equivalent to powering 44,000 U.S. homes for a year. The company's products also replaced over 32,000 tons of synthetic fertilizer, delivering greater ROI and higher margins for farmers. The data suggests that Pivot Bio's technology is enabling farmers to improve productivity and profitability without contributing to climate change.
Pivot Bio, a US-based company, has developed two bacteria-based treatments that can replace about a quarter of the synthetic nitrogen used in fertilisers without affecting crop yield. The treatments, which can be applied directly to the soil or as a coating on seeds, are now being used on over 3 million acres of farmland in the US. The company estimates that this has resulted in a reduction in greenhouse gas emissions equivalent to 220,000 tonnes of CO2.
Updated on: Nov 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.